10x Genomics, Inc.
10x Genomics, Inc. (TXG) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 1010 transactions totaling $284.6M, demonstrating a bearish sentiment with -$284.6M in net insider flow. The most recent transaction on Feb 23, 2026 involved a sale of 7,826 shares valued at $145.4K.
TXG Insider Activity Summary
Who Is Buying TXG Stock?
No significant insider buying has been recorded for TXG in the recent period.
Who Is Selling TXG Stock?
No significant insider selling has been recorded for TXG in the recent period.
Is 10x Genomics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for TXG is bearish with an Insider Alignment Score of 0/100 and a net flow of -$284.6M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
TXG Frequently Asked Questions
Understanding TXG Insider Activity
Insider trading at 10x Genomics, Inc. (TXG) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading TXG stock, having executed 1010 transactions in the past 90 days. The most active insider is Benjamin J. Hindson (Executive), who has made 185 transactions totaling $120.7M.
Related Tools
Track 10x Genomics, Inc. Insider Activity
Get notified when executives and directors at TXG file new Form 4 transactions